How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.

Journal of Market Access & Health Policy
Baudouin StandaertSharon Zhang

Abstract

Background:Cost-effectiveness analysis (CEA) is the economic analysis method most commonly applied today in the context of replacing one treatment with a new one in a developed healthcare system to improve efficiency. CEA is often requested by local healthcare decision-makers to grant reimbursement. New preventative interventions, such as new vaccines, may however have much wider benefits inside and outside healthcare, when compared with treatment. These additional benefits include externalities on indirect clinical impact, reallocation of specific healthcare resources, improved quality of care, better productivity, better disease control, better fiscal revenues, and others. But these effects are sometimes difficult to integrate into a meaningful CEA result. They may appear as specific benefits for specific stakeholders, other than the stakeholders in healthcare. Objective: Based on a historical view about the application of economic assessments for vaccines our objective has been to make the inventory of who was/is interested in knowing the economic value of vaccines, in what those different stakeholders are likely to see the benefit from their perspective and how  were/are we able to measure those benefits and to report them ...Continue Reading

References

Jan 1, 1991·International Journal of Technology Assessment in Health Care·B JönssonL Matter
Jul 1, 1983·The Journal of Infection·J L DienstagA G Mulley
Sep 4, 1980·The New England Journal of Medicine·J S WillemsJ C Bell
Dec 31, 1997·American Journal of Epidemiology·M E HalloranI M Longini
Jan 7, 1997·Journal of Health Economics·A M Garber, C E Phelps
Feb 6, 1998·PharmacoEconomics·J A MauskopfA Stergachis
Mar 25, 2000·JAMA : the Journal of the American Medical Association·T A LieuH R Shinefield
Jan 23, 2002·Vaccine·M Brisson, W J Edmunds
Aug 20, 2005·BMJ : British Medical Journal·Werner B F BrouwerFrans F H Rutten
Nov 26, 2008·Vaccine·Nicole FerkoMichael Drummond
Nov 11, 2008·The Lancet Infectious Diseases·Philippe BeutelsC Raina MacIntyre
Nov 4, 2009·Annals of Internal Medicine·Aaron L NelsonDavid M Kent
Jan 26, 2011·International Journal of Technology Assessment in Health Care·Irina CleemputMark Leys
Dec 3, 2011·Vaccine·Katherine E AtkinsAlison P Galvani
Sep 24, 2013·Vaccine·Nikolaos KotsopoulosRaymond C W Hutubessy
Jan 24, 2014·Cost Effectiveness and Resource Allocation : C/E·Baudouin A StandaertMaarten J Postma
Feb 12, 2014·PharmacoEconomics·Simon Eckermann, Brita Pekarsky
Mar 19, 2014·Lancet·Seth Berkley
Aug 12, 2014·The Lancet Global Health·Till BärnighausenDamian Walker
Dec 30, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Arthur E Attema
Apr 25, 2015·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Miqdad AsariaRichard Cookson
May 16, 2015·Risk Analysis : an Official Publication of the Society for Risk Analysis·Eugene LamJames L Goodson
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Praveen ThokalaMaarten Ijzerman
Jan 26, 2016·Vaccine·Mitra Saadatian-ElahiChristopher B Nelson
Feb 3, 2016·Applied Health Economics and Health Policy·Mark Jit, Raymond Hutubessy
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kevin MarshUNKNOWN ISPOR Task Force
Jan 1, 2015·Journal of Market Access & Health Policy·Thomas SzucsMarina Panfilo
Jan 1, 2015·Journal of Market Access & Health Policy·Paolo BonanniVanessa Rémy
Jan 1, 2015·Journal of Market Access & Health Policy·Nathalie LargeronXavier Bresse
Jul 5, 2016·PharmacoEconomics·Stéphane VerguetDean T Jamison
Jul 28, 2016·Health Policy and Planning·Lisa A RobinsonStephen Resch
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Laura Vallejo-TorresPedro Serrano-Aguilar
Oct 25, 2016·Vaccine·Mark DohertyDavid Prado-Cohrs
Feb 27, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonAdrian Towse
Feb 27, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mark P ConnollyAomesh Bhatt

❮ Previous
Next ❯

Citations

Dec 5, 2020·Expert Review of Vaccines·Philippe BuchyGyneth Lourdes Bibera
Aug 10, 2021·Journal of Market Access & Health Policy·Christophe SauboinBaudouin Standaert

❮ Previous
Next ❯

Software Mentioned

Cauliflower
ECEA
MCDA
CEA
BIA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.